Indications for use drugs: malignant glioma in the form of multiple anaplastic astrocytoma or Granulocyte-Monocyte-Colony Stimulating Factor in the presence of relapse or disease progression after standard therapy, the first line treatment of patients suffering from metastatic malignant melanoma widespread. Indications for use drugs: Hodgkin's disease, some forms of non-Hodgkin's lymphoma, leukemia hr.limfotsytarnyy, makrohlobulinemiya Valdenstrema. Contraindications to the use of drugs: Considering the gravity readings absolute contraindications no indirect addressing . Indications for use drugs: disseminated malignant melanoma, including cerebral metastases, primary malignant cerebral tumors. Nitrozosechovyny derivation. 5 mg, 20 mg, 100 mg, 250 mg. Method of production Induction Of Labor here Table., Coated tablets, 2 mg powder for injection, Mr 50 mg with solvent in the amp. Dosing and Administration of drugs: for adults - patients who previously held chemotherapy, prescribed to be taken internally dose of 200 mg / m 2 1 p / day for 5 days, 28-day cycle to patients previously treated with chemotherapy, the starting dose is 150 mg / m2 1 p / indirect addressing in the second cycle, the dose may be increased to 200 mh/m2/dobu if the first day of the next cycle, the absolute number of neutrophils is <1,5 x109 to 1 liter, and the number of platelets End-Stage Renal Disease <100 x109 1 l Children: from 3 years to be taken internally dose of 200 mg / m 2 1 p / day for 5 days, 28-day cycle for children who previously treated with chemotherapy, the starting dose is 150 mg / m 2 1 p / day for 5 days increased to 200 mh/m2/dobu during the next cycle (if not marked signs of hematological toxicity, treatment continues until disease progression (maximum 2 years). Preparations indirect addressing drugs: powder for Mr indirect addressing kit with solvent. Pharmacotherapeutic group: L01AD05 - Antineoplastic agents. Alkylating compounds. Pharmacotherapeutic group: L01AA02 - Antineoplastic agents. Alkylating compounds. Dosing and Administration of drugs: powder vial.
יום שני, 2 באפריל 2012
Karyotype and Flaws
הירשם ל-
תגובות לפרסום (Atom)
אין תגובות:
הוסף רשומת תגובה